Scientists at Oak Ridge National Laboratory and six other Department of Energy national laboratories have developed a United States-based perspective for achieving net-zero carbon emissions.
Integral to the functionality of ORNL's Frontier supercomputer is its ability to store the vast amounts of data it produces onto its file system, Orion. But even more important to the computational scientists running simulations on Frontier is their capability to quickly write and read to Orion along with effectively analyzing all that data. And that’s where ADIOS comes in.
Chuck Greenfield, former assistant director of the DIII-D National Fusion Program at General Atomics, has joined ORNL as ITER R&D Lead.
ORNL and the University of Tennessee, Knoxville, co-hosted the 2023 National Society of Black Physicists Annual Conference with the theme "Frontiers in Physics: From Quantum to Materials to the Cosmos.” As part of the three-day conference held near UT, attendees took a 30-mile trip to the ORNL campus for facility tours, science talks and workshops.
New computational framework speeds discovery of fungal metabolites, key to plant health and used in drug therapies and for other uses.
In summer 2023, ORNL's Prasanna Balaprakash was invited to speak at a roundtable discussion focused on the importance of academic artificial intelligence research and development hosted by the White House Office of Science and Technology Policy and the U.S. National Science Foundation.
The INFUSE fusion program announced a second round of 2020 public-private partnership awards to accelerate fusion energy development.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Chuck Kessel was still in high school when he saw a scientist hold up a tiny vial of water and say, “This could fuel a house for a whole year.”
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.